Bicycle, Roche collab for immuno-oncology therapies
Under the terms of the agreement, the companies will collaborate on the discovery and pre-clinical development of novel Bicycle-based immunotherapies against multiple targets.
Read More
Tag: Bicycle
Bicycle, CR UK launch first trial of a bicyclic peptide
Bicycle Therapeutics and Cancer Research UK have initiated the first clinical study to assess a bicyclic peptide, evaluating its potential in patients with advanced solid tumours.
Read More
Bicycle raises £40m to advance pipeline
UK biotech Bicycle Therapeutics has raised an impressive £40 million to help advance its lead candidate, cancer drug BT1718, into the clinic trials later this year.
Read More
Bicycle, CR UK work together on new cancer drugs
Cancer Research UK, Cancer Research Technology (CRT) and UK biotech Bicycle Therapeutics have formed a pact to trial a first-in-class experimental drug for cancers of high unmet need.
Read More
AZ, Bicycle pair up to develop bicyclic peptides
AstraZeneca and Bicycle Therapeutics have entered into a deal to develop bicyclic peptides that could net the latter firm more than $1 billion if all pre-specified targets are met.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
